Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by FredTheVoiceon Nov 06, 2018 10:08am

213 Views

Post# 28930040

RE:Short-term catalysists.

WOW. Great post.

SmartMitch;

One point that we are not on the same opinion line:
POINT 3:
TANGUAY will deliver: and we can say...........60% chance; and HUGE effect. MY opinion
THAN,
that changes your conclusion: if it happens: END OF YEAR STOCK PRICE: 16$C.

For the rest, very intersting.

But you underestimate the money makers that are jumping in since a couple of weeks (6$ 7$ 8$....). They will bring that stock price to beat the 52 year HIGH if goods news continues to flow in.

FTV.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?